NO20016316D0 - Fremgangsmåte til å behandle eller forhindre kransarterietransplantasjonsvasospasme - Google Patents

Fremgangsmåte til å behandle eller forhindre kransarterietransplantasjonsvasospasme

Info

Publication number
NO20016316D0
NO20016316D0 NO20016316A NO20016316A NO20016316D0 NO 20016316 D0 NO20016316 D0 NO 20016316D0 NO 20016316 A NO20016316 A NO 20016316A NO 20016316 A NO20016316 A NO 20016316A NO 20016316 D0 NO20016316 D0 NO 20016316D0
Authority
NO
Norway
Prior art keywords
vasospasm
coronary artery
treating
preventing coronary
transplant
Prior art date
Application number
NO20016316A
Other languages
English (en)
Other versions
NO320315B1 (no
NO20016316L (no
Inventor
Lasse Lehtonen
Julius Gy Papp
Janos Szecsi
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20016316D0 publication Critical patent/NO20016316D0/no
Publication of NO20016316L publication Critical patent/NO20016316L/no
Publication of NO320315B1 publication Critical patent/NO320315B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Graft Or Block Polymers (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20016316A 1999-06-29 2001-12-21 Anvendelse av levosimendan til fremstilling av et medikament for behandling av koronar transplantasjonsvasospasme NO320315B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9915179.7A GB9915179D0 (en) 1999-06-29 1999-06-29 A method for the treatment or prevention of coronary graft vasospasm
PCT/FI2000/000592 WO2001000211A1 (en) 1999-06-29 2000-06-29 A method for the treatment or prevention of coronary graft vasospasm

Publications (3)

Publication Number Publication Date
NO20016316D0 true NO20016316D0 (no) 2001-12-21
NO20016316L NO20016316L (no) 2002-01-30
NO320315B1 NO320315B1 (no) 2005-11-21

Family

ID=10856266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016316A NO320315B1 (no) 1999-06-29 2001-12-21 Anvendelse av levosimendan til fremstilling av et medikament for behandling av koronar transplantasjonsvasospasme

Country Status (19)

Country Link
US (1) US6593329B1 (no)
EP (1) EP1191935B1 (no)
JP (1) JP4628622B2 (no)
KR (1) KR100762023B1 (no)
AT (1) ATE293446T1 (no)
AU (1) AU767361B2 (no)
BR (1) BR0012072A (no)
CA (1) CA2376930C (no)
CZ (1) CZ294751B6 (no)
DE (1) DE60019591T2 (no)
EA (1) EA004142B1 (no)
ES (1) ES2240110T3 (no)
GB (1) GB9915179D0 (no)
HU (1) HU228302B1 (no)
NO (1) NO320315B1 (no)
NZ (1) NZ516395A (no)
PL (1) PL199973B1 (no)
SK (1) SK285428B6 (no)
WO (1) WO2001000211A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104718B (fi) * 1998-06-18 2000-03-31 Orion Yhtymae Oyj [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
FI20001542A (fi) * 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
JP5781727B2 (ja) * 2007-02-23 2015-09-24 株式会社ネクスト２１ 血管攣縮の治療剤又は予防剤
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
CZ294751B6 (cs) 2005-03-16
BR0012072A (pt) 2002-04-02
HUP0202085A3 (en) 2003-02-28
PL199973B1 (pl) 2008-11-28
EP1191935B1 (en) 2005-04-20
WO2001000211A1 (en) 2001-01-04
AU5687900A (en) 2001-01-31
SK19342001A3 (sk) 2002-07-02
GB9915179D0 (en) 1999-09-01
JP2003503353A (ja) 2003-01-28
ES2240110T3 (es) 2005-10-16
CA2376930C (en) 2008-07-29
EA004142B1 (ru) 2004-02-26
KR100762023B1 (ko) 2007-10-04
HUP0202085A2 (hu) 2002-12-28
US6593329B1 (en) 2003-07-15
PL352779A1 (en) 2003-09-08
DE60019591D1 (de) 2005-05-25
EA200200100A1 (ru) 2002-06-27
DE60019591T2 (de) 2006-03-02
EP1191935A1 (en) 2002-04-03
CA2376930A1 (en) 2001-01-04
SK285428B6 (sk) 2007-01-04
NO320315B1 (no) 2005-11-21
AU767361B2 (en) 2003-11-06
NO20016316L (no) 2002-01-30
HU228302B1 (en) 2013-03-28
JP4628622B2 (ja) 2011-02-09
CZ20014685A3 (cs) 2002-08-14
KR20020020743A (ko) 2002-03-15
ATE293446T1 (de) 2005-05-15
NZ516395A (en) 2005-02-25

Similar Documents

Publication Publication Date Title
DE69201640D1 (de) (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propandinitril.
WO2004024093A3 (en) Device and method for treating restenosis
NO20016316D0 (no) Fremgangsmåte til å behandle eller forhindre kransarterietransplantasjonsvasospasme
PL345467A1 (en) Method of treating pulmonary hypertension
YU63900A (sh) Peroralne kompozicije koje kontrolisano oslobađaju levosimendan
DE60104693D1 (de) Behandlung von septischem schock
WO2002047603A3 (en) Use of levosimendan for treating erictile dysfunction
DE60016038D1 (de) Neue verwendung von levosimendan

Legal Events

Date Code Title Description
MK1K Patent expired